Day 3 Highlights of ECTRIMS 2024

Biomarkers are one of the most exciting and fast-evolving areas in multiple sclerosis research, offering promise for earlier diagnosis, accurate prognosis, and truly personalised treatment. Yet despite their potential, there is still significant debate that limits their widesprea ... Show More

Over the past few years, the MS research community has been following developments in a new class of therapies called Bruton's tyrosine kinase inhibitors (BTKis). At ECTRIMS 2024, the results of two tolebrutinib trials were presented as late-breaking abstracts by Dr. Robert Fox, ... Show More

What do the latest research findings tell us about the role diet can play in the management of multiple sclerosis (MS)? How should neurologists talk about diet with their patients? While people living with MS may view their food choices as a way to exert some control over the dis ... Show More

Multiple Sclerosis is a complex disease that can take a long time to diagnose and may present with a multitude of symptoms - explaining why it is sometimes referred to as "The disease with a thousand faces." In this Listen Well episode, host Dr. Mo Alsuwaidan delves into the pati ... Show More

Maladie génétique rare et héréditaire du système nerveux central, la maladie de Huntington se manifeste par des troubles psychiatriques, cognitifs et moteurs qui s’aggravent progressivement. Les symptômes de la maladie se manifestent généralement entre 30 et 50 ans. Elle est d'év ... Show More

The August 2024 recall showcases four previously posted episodes on the topic of Multiple Sclerosis. In the first episode, Dr. Géraldine Androdias discusses the impact of immune checkpoint inhibitors on multiple sclerosis. The episode leads into Dr. Bob Fox discussing the relatio ... Show More

Are you tired of feeling tired all the time? You're not alone—burnout is one of the most common complaints I hear from patients. In this episode, I dive into the root causes of chronic fatigue, including how mitochondrial dysfunction could be sabotaging your energy levels. I’ll s ... Show More

Maladie neurodégénérative chronique, la maladie d’Alzheimer entraîne une perte progressive et irréversible des cellules cérébrales. Altération de la mémoire, de l’orientation dans le temps et l’espace… Le patient perd peu à peu son autonomie. Comment reconnaître et diagnostiquer ... Show More

Coeliac disease affects 1% of the population, however it remains under diagnosed. In a disease which is mainly managed by diet, why do we need to investigate and make a formal diagnosis? In this podcast Dr Sam Robinson talks to Professor David Sanders, Professor of Gastroenterolo ... Show More

Liara presents with relapsing-remitting multiple sclerosis with complaints of fatigue and difficulty walking. She reports worsening symptoms in the afternoon but denies any new relapses. Examination reveals mild spasticity in the lower limbs, decreased endurance, and poor postura ... Show More

Multiple Sclerosis (MS) is a neurological disease which can lead to loss of mobility and vision. Almost 3 million people worldwide are affected by it. There is no cure, but attempts are being made to accelerate the healing process with treatments to restore what the disease has d ... Show More

Dale E. Bredesen Dale E. Bredesen, M.D., is a professor of neurology at the Easton Laboratories for Neurodegenerative Disease Research at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Bredesen's laboratory focuses on identifying and ... Show More